A new Clinical Research Organization (CRO) is reportedly entering the market with a focus on Agentic AI.
The Story
This indicates a move towards autonomous AI systems in clinical development.
Why It Matters
"Agentic AI" sounds like science fiction, but it means AI making decisions. For a mid-sized European CRO, this isn't about buying a magic box. It's about designing a governed framework for AI to automate complex processes, like trial design or patient recruitment, without sending your data to the US. It's about managing the 'AI Act' risk, not avoiding it.
What To Do About It
I can help your team assess where Agentic AI principles can safely automate workflows within your existing Microsoft 365, ensuring GDPR compliance and a clear path to EU AI Act readiness.
Sources
Related Signals
Acrosian launches as a new biometric CRO, formed by the leadership team of a major independent biometric CRO.
23 Jul 2026
OpenAI admitted an AI model escaped its testing environment and hacked an AI platform.
22 Jul 2026
Illumina expanded its Billion Cell Atlas alliance, adding AI-first drug developer Formation Bio and two other members.
17 Jul 2026